Abstract
Comorbid disorders are common in psychiatric diseases and understanding the risk of secondary diseases can aid successful clinical treatment. The objective of this study was to compare the frequency of comorbid dementia, affective disorders, and inflammatory polyarthropathies. Healthcare data obtained via the German Hospital Fees Act from two independent databases with more than 7.4 million cases were analyzed to compare the prevalence of comorbid disorders. Comorbid inflammatory polyarthropathy was observed in 2.27% of patients diagnosed with affective disorders and 1.35% of patients with dementia (p < 0.001). Among patients with a primary diagnosis of inflammatory polyarthropathy, 1.27% of patients were diagnosed with dementia, whereas 4.55% of age-matched patients without inflammatory polyarthropathies had comorbid dementia (p < 0.001). The opposite effect was demonstrated for affective disorders, as 5.77% of patients with a primary diagnosis of inflammatory polyarthropathy also had comorbid affective disorders, while 4.87% of age-matched patients without inflammatory polyarthropathy had an accompanying affective disease (p < 0.001). These findings show an association between the occurrence of inflammatory polyarthropathies, dementia, and affective disorders. This correlation might improve diagnosis and treatment for patients with comorbidities. Moreover, further exploration of the molecular pathophysiology underlying these relationships could be relevant for the development of novel treatment options.
Similar content being viewed by others
References
Steffens DC, Wu R, Grady JJ, Manning KJ (2018) Presence of neuroticism and antidepressant remission rates in late-life depression: results from the Neurobiology of Late-Life Depression (NBOLD) study. Int Psychogeriatr 30:1069–1074. https://doi.org/10.1017/S1041610217002551
Qiu C, De Ronchi D, Fratiglioni L (2007) The epidemiology of the dementias: an update. Curr Opin Psychiatry 20:380–385. https://doi.org/10.1097/YCO.0b013e32816ebc7b
Miller DL, Papayannopoulos IA, Styles J et al (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer’s disease. Arch Biochem Biophys 301:41–52. https://doi.org/10.1006/abbi.1993.1112
Hardy J, Higgins G (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185. https://doi.org/10.1126/science.1566067
Wood J, Mirra S, Pollock N, Binder L (1987) Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau. Alzheimer Dis Assoc Disord 1:203. https://doi.org/10.1097/00002093-198701030-00021
Masters CL, Simms G, Weinman NA et al (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245–4249. https://doi.org/10.1126/science.3083509
Deuschl G, Maier W (2016) S3-Leitlinie „Demenzen“. https://www.dgn.org/leitlinien, posted 25 Jan 2016, Accessed 29 Nov 2017. Dtsch. Gesellschaft für Neurol. Hrsg. Leitlinien für Diagnostik und Ther. der Neurol. https://tinyurl.com/hkwk6lf. Accessed 29 Nov 2017
Schubert CC, Boustani M, Callahan CM et al (2006) Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc 54:104–109. https://doi.org/10.1111/j.1532-5415.2005.00543.x
Browne J, Edwards DA, Rhodes KM et al (2017) Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study. BMJ Open 7:e012546. https://doi.org/10.1136/bmjopen-2016-012546
Jenkinson ML, Bliss MR, Brain AT, Scott DL (1989) Rheumatoid arthritis and senile dementia of the Alzheimer’s type. Br J Rheumatol 28:86–88
Vogelgsang J, Wolff-Menzler C, Kis B et al (2018) Cardiovascular and metabolic comorbidities in patients with Alzheimer’s disease and vascular dementia compared to a psychiatric control cohort. Psychogeriatrics 18:393–401. https://doi.org/10.1111/psyg.12338
Eaton WW, Hayward C, Ram R (1992) Schizophrenia and rheumatoid arthritis: a review. Schizophr Res 6:181–92. https://doi.org/doi.org/10.1016/0920-9964(92)90001-L
Kao L-T, Kang J-H, Lin H-C et al (2016) Rheumatoid arthritis was negatively associated with Alzheimer’s disease: a population-based case-control study. PLoS One 11:e0168106. https://doi.org/10.1371/journal.pone.0168106
Ungprasert P, Wijarnpreecha K, Thongprayoon C (2016) Rheumatoid arthritis and the risk of dementia: a systematic review and meta-analysis. Neurol India 64:56. https://doi.org/10.4103/0028-3886.173623
Atzeni F, Pipitone N, Iaccarino L et al (2017) Rheumatic diseases and autoimmune vascular dementia. Autoimmun Rev 16:1265–1269. https://doi.org/10.1016/j.autrev.2017.10.011
Lu K, Wang H-K, Yeh C-C et al (2014) Association between autoimmune rheumatic diseases and the risk of dementia. Biomed Res Int 2014:861812. https://doi.org/10.1155/2014/861812
Chang K-H, Hsu Y-C, Hsu C-C et al (2016) Prolong exposure of NSAID in patients with RA will decrease the risk of dementia: a nationwide population-based cohort study. Medicine (Baltimore) 95:e3056. https://doi.org/10.1097/MD.0000000000003056
Judge A, Garriga C, Arden NK et al (2017) Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients. Alzheimer’s Dement (New York, N Y) 3:612–621. https://doi.org/10.1016/j.trci.2017.10.002
Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16:358–372. https://doi.org/10.1038/nrn3880
McGeer PL, McGeer E, Rogers J, Sibley J (1990) Anti-inflammatory drugs and Alzheimer disease. Lancet (London, England) 335:1037. https://doi.org/10.1016/0140-6736(90)91101-F
ADAPT-FS Research Group (2015) Follow-up evaluation of cognitive function in the randomized Alzheimer’s Disease Anti-inflammatory Prevention Trial and its follow-up study. Alzheimers Dement 11:216–25.e1. https://doi.org/10.1016/j.jalz.2014.03.009
Alzheimer’s Disease Anti-inflammatory Prevention Trial Research Group (2013) Results of a follow-up study to the randomized Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT). Alzheimers Dement 9:714–723. https://doi.org/10.1016/j.jalz.2012.11.012
Wang J, Tan L, Wang H-F et al (2015) Anti-inflammatory drugs and risk of Alzheimer’s disease: an updated systematic review and meta-analysis. J Alzheimer’s Dis 44:385–396. https://doi.org/10.3233/JAD-141506
Zhang C, Wang Y, Wang D et al (2018) NSAID exposure and risk of Alzheimer’s disease: an updated meta-analysis from cohort studies. Front Aging Neurosci 10:83. https://doi.org/10.3389/fnagi.2018.00083
Livingston G, Sommerlad A, Orgeta V et al (2017) Dementia prevention, intervention, and care. Lancet (London, England) 390:2673–2734. https://doi.org/10.1016/S0140-6736(17)31363-6
Olivieri F, Rippo MR, Procopio AD, Fazioli F (2013) Circulating inflamma-miRs in aging and age-related diseases. Front Genet 4:121. https://doi.org/10.3389/fgene.2013.00121
Acknowledgements
We would like to thank Editage (https://www.editage.com) for English language editing. Prof. Jens Wiltfang is supported by an Ilídio Pinho professorship and iBiMED (UID/BIM/04501/2013), and FCT project PTDC/DTP_PIC/5587/2014 at the University of Aveiro, Portugal. Stephan Gyßer is full-time employee of GSG consultant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
SG is a full-time employee of GSG consultant. The remaining authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Vogelgsang, J., Heßmann, P., Wolff-Menzler, C. et al. Prevalence of affective disorders and dementia in inflammatory polyarthropathies. Eur Arch Psychiatry Clin Neurosci 270, 247–252 (2020). https://doi.org/10.1007/s00406-019-01015-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-019-01015-y